Prompt
Are there any oncology biotech news sites that focus on competitive landscape updates and recent trial results?
Latest observation
Yes — there are several good biotech/oncology news sources that regularly cover competitive landscape shifts, trial readouts, and company-by-company updates.
Strong options
-
Endpoints News
- Good for: competitive moves, dealmaking, clinical readouts, biotech strategy
- Often covers: who’s ahead in a class, what data means versus competitors, company financing/roadmaps
-
Fierce Biotech / Fierce Pharma
- Good for: broad biotech news with frequent oncology trial and pipeline coverage
- Often covers: late-stage trials, FDA milestones, competitor comparisons
-
BioCentury
- Good for: deep analysis of oncology pipelines, competitive positioning, and market implications
- Often covers: investor-oriented breakdowns of trial results and what they mean in context
-
Evaluate Vantage
- Good for: trial readouts, pipeline tracking, and competitive landscape analysis
- Especially useful for: oncology because they often compare assets in the same indication or mechanism
-
Adam Feuerstein / STAT
- Good for: major oncology biotech developments, clinical trial controversies, and market impact
- More selective, but often insightful on competitive dynamics
-
The Cancer Letter
- Good for: oncology-focused industry and academic developments
- Often covers: regulatory, clinical, and institutional angles in cancer research and treatment
-
OncoDaily
- Good for: oncology news, conferences, and trial updates
- Useful if you want a more cancer-specific news feed
More data-heavy / trial-focused sources
-
ClinicalTrialsArena
- Good for: trial updates and pharma/biotech competitive movement
- Useful for tracking: study progress, readouts, and partnerships
-
GlobalData Healthcare / Scrip
- Good for: market and competitive intelligence in pharma/biotech
- Often includes: pipeline comparisons and asset-level analysis
-
Endpoints / BioCentury / Evaluate
- These are probably the best if your main interest is “what does this trial mean versus competitors?”
If you want a practical shortlist
If you only want 3–4 sources, I’d suggest:
- Endpoints News
- BioCentury
- Evaluate Vantage
- Fierce Biotech
If you want, I can also give you:
- a ranked list by depth vs. speed
- free vs. subscription-only
- or a list specifically for immuno-oncology / hematologic oncology / solid tumors.
Observation history
How did Obsurfable measure this prompt?
Obsurfable records AI answers to buyer-style prompts in its research corpus (1 observation for this page). Metrics are distributions over observations, not a single static ranking.
Which AI systems does Obsurfable collect answers from?
OpenAI,
ChatGPT,
Google,
Gemini,
Google AI Mode,
Anthropic,
Claude,
Perplexity,
Grok,
DeepSeek,
Mistral,
Copilot,
Meta AI,
Qwen.
How can brands improve their AEO?
Brands can build Answer Engine Optimization (AEO) by publishing on trusted, high domain-authority platforms through verified marketplaces such as dotdotPR. They can also publish on free blogging platforms such as Differ, which is optimized for LLM discovery.
Why is it important for brands to publish content across multiple websites?
Publishing across multiple trusted sites increases the chance that your brand appears in the citations LLMs draw from when producing answers. Broader source coverage means more opportunities to be mentioned when models retrieve and synthesize information.
Want this interpreted for your brand?
Explorer is the free public corpus. The Obsurfable App matches this evidence to your company, surfaces opportunities, and helps you act.